The correct usage and dosage of larotrectinib (Vitacai) and daily taking recommendations

Larotrectinib is an oral small molecule TRK inhibitor, mainly used for adult and pediatric patients with TRK fusion-positive advanced or metastatic solid tumors. The drug achieves anti-tumor effects by inhibiting the abnormal activity of TRK family tyrosine kinases and blocking tumor cell proliferation and survival signals. The dosage regimen of larotrectinib must be strictly followed by a physician to ensure maximum efficacy and reduce the risk of adverse reactions.

The standard dosage is 100 mg twice daily (morning and evening), which can be taken with food or on an empty stomach. In this way, the total daily dose is 200 mg, which can ensure stable drug concentration in the body and exert the best anti-tumor effect. For children or underweight patients, dosage should be individually adjusted based on body weight or body surface area to ensure drug safety and tolerability. Patients should strictly follow the doctor's instructions and should not increase or decrease the dosage or stop medication at will.

During the treatment process, patients should regularly monitor blood routine, liver, kidney and heart functions, and pay attention to possible adverse reactions, including fatigue, nausea, vomiting, abnormal liver function and mild gastrointestinal reactions. If serious adverse reactions occur, the dose should be adjusted in time or the medication should be suspended under the guidance of a doctor to reduce drug risks. Correct monitoring and timely treatment of adverse reactions are important measures to ensure the long-term therapeutic effect of larotrectinib.

Larotrectinib usually needs to be continued until disease progression or unacceptable toxicity occurs. Taking it regularly twice a day and cooperating with regular medical examinations can maximize the efficacy of the drug and reduce the incidence of adverse reactions. In addition, patients should maintain close communication with their doctors during medication and provide timely feedback on their physical conditions so that doctors can make dosage adjustments and risk management to achieve safe and effective long-term treatment.

Reference link:https://www.drugs.com